LISA NOE: Open Payments
NPI 1063566743 · CUSHING, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,917 in 100 payments from 23 companies in 2025. Trend: 2023 $1,738 · 2024 $1,914 · 2025 $1,917
Food & beverage: $1,917
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 12 | $328 |
| ABBVIE INC. | 20 | $210 |
| AstraZeneca Pharmaceuticals LP | 10 | $189 |
| Otsuka America Pharmaceutical, Inc. | 3 | $170 |
| Lilly USA, LLC | 8 | $154 |
| Lundbeck LLC | 6 | $125 |
| GlaxoSmithKline, LLC. | 7 | $118 |
| PFIZER INC. | 6 | $99 |
| Viatris Specialty LLC | 5 | $96 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $65 |
Products named: REXULTI, Auvelity, Symbravo, BREZTRI, VRAYLAR, TRELEGY ELLIPTA, MOUNJARO, YUPELRI.
Industry payments across OK — which companies pay providers there.
